---
reference_id: "PMID:37103614"
title: Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy.
authors:
- Shimazu Y
- Mizumoto C
- Chonabayashi K
- Hanyu Y
- Kanda J
- Takaori-Kondo A
journal: Ann Hematol
year: '2023'
doi: 10.1007/s00277-023-05215-4
content_type: abstract_only
---

# Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy.
**Authors:** Shimazu Y, Mizumoto C, Chonabayashi K, Hanyu Y, Kanda J, Takaori-Kondo A
**Journal:** Ann Hematol (2023)
**DOI:** [10.1007/s00277-023-05215-4](https://doi.org/10.1007/s00277-023-05215-4)

## Content

1. Ann Hematol. 2023 Aug;102(8):2291-2292. doi: 10.1007/s00277-023-05215-4. Epub 
2023 Apr 27.

Successful treatment with cyclosporine of pure red cell aplasia induced by 
obinutuzumab bendamustine therapy.

Shimazu Y(1), Mizumoto C(2), Chonabayashi K(1), Hanyu Y(1), Kanda J(1), 
Takaori-Kondo A(1).

Author information:
(1)Department of Hematology and Oncology, Graduate School of Medicine, Kyoto 
University, 54, Kyoto, Kawaramachi, Shogoin, Sakyoku, 606-8507, Japan.
(2)Department of Hematology and Oncology, Graduate School of Medicine, Kyoto 
University, 54, Kyoto, Kawaramachi, Shogoin, Sakyoku, 606-8507, Japan. 
cmizumo@kuhp.kyoto-u.ac.jp.

DOI: 10.1007/s00277-023-05215-4
PMID: 37103614 [Indexed for MEDLINE]